aluates Reports

$ 0.0

Automative

Global Gene Delivery System Technology Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-5M5462

Global Gene Delivery System Technology Drug Market Size Status and Forecast 2021 2027

BUY CHAPTERS

Global Gene Delivery System Technology Drug Market Research Report 2025

Code: QYRE-Auto-5M5462

Report

July 2025

Pages:89

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen Inc

Spark Therapeutics

Akcea Therapeutics

Bluebird bio

Sunway Biotech

Sibiono

AnGes

Orchard Therapeutics

Human Stem Cells Institute

Gene Delivery System Technology Drug Market Size

The global market for Gene Delivery System Technology Drug was valued at US$ 13690 million in the year 2024 and is projected to reach a revised size of US$ 48640 million by 2031, growing at a CAGR of 20.2% during the forecast period.

Gene Delivery System Technology Drug Market

Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient"s cells instead of using drugs or surgery.

The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.

This report aims to provide a comprehensive presentation of the global market for Gene Delivery System Technology Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Delivery System Technology Drug.

The Gene Delivery System Technology Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Delivery System Technology Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Delivery System Technology Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Delivery System Technology Drug Market Report

Report Metric	Details
Report Name	Gene Delivery System Technology Drug Market
Accounted market size in year	US$ 13690 million
Forecasted market size in 2031	US$ 48640 million
CAGR	20.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Viral Gene Delivery System Non-viral Gene Delivery System
Segment by Application	Neurological Diseases Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Delivery System Technology Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Delivery System Technology Drug Market growing?

Ans: The Gene Delivery System Technology Drug Market witnessing a CAGR of 20.2% during the forecast period 2025-2031.

What is the Gene Delivery System Technology Drug Market size in 2031?

Ans: The Gene Delivery System Technology Drug Market size in 2031 will be US$ 48640 million.

Who are the main players in the Gene Delivery System Technology Drug Market report?

Ans: The main players in the Gene Delivery System Technology Drug Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene Delivery System Technology Drug Market report?

Ans: The Applications covered in the Gene Delivery System Technology Drug Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Gene Delivery System Technology Drug Market report?

Ans: The Types covered in the Gene Delivery System Technology Drug Market report are Viral Gene Delivery System, Non-viral Gene Delivery System

Recommended Reports

Gene Therapy Markets

Delivery Technologies

Gene Editing & Advanced

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Delivery System Technology Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Viral Gene Delivery System

1.2.3 Non-viral Gene Delivery System

1.3 Market by Application

1.3.1 Global Gene Delivery System Technology Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Neurological Diseases

1.3.3 Cancer

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Delivery System Technology Drug Market Perspective (2020-2031)

2.2 Global Gene Delivery System Technology Drug Growth Trends by Region

2.2.1 Global Gene Delivery System Technology Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Gene Delivery System Technology Drug Historic Market Size by Region (2020-2025)

2.2.3 Gene Delivery System Technology Drug Forecasted Market Size by Region (2026-2031)

2.3 Gene Delivery System Technology Drug Market Dynamics

2.3.1 Gene Delivery System Technology Drug Industry Trends

2.3.2 Gene Delivery System Technology Drug Market Drivers

2.3.3 Gene Delivery System Technology Drug Market Challenges

2.3.4 Gene Delivery System Technology Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Delivery System Technology Drug Players by Revenue

3.1.1 Global Top Gene Delivery System Technology Drug Players by Revenue (2020-2025)

3.1.2 Global Gene Delivery System Technology Drug Revenue Market Share by Players (2020-2025)

3.2 Global Gene Delivery System Technology Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Gene Delivery System Technology Drug Revenue

3.4 Global Gene Delivery System Technology Drug Market Concentration Ratio

3.4.1 Global Gene Delivery System Technology Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Technology Drug Revenue in 2024

3.5 Global Key Players of Gene Delivery System Technology Drug Head office and Area Served

3.6 Global Key Players of Gene Delivery System Technology Drug, Product and Application

3.7 Global Key Players of Gene Delivery System Technology Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Delivery System Technology Drug Breakdown Data by Type

4.1 Global Gene Delivery System Technology Drug Historic Market Size by Type (2020-2025)

4.2 Global Gene Delivery System Technology Drug Forecasted Market Size by Type (2026-2031)

5 Gene Delivery System Technology Drug Breakdown Data by Application

5.1 Global Gene Delivery System Technology Drug Historic Market Size by Application (2020-2025)

5.2 Global Gene Delivery System Technology Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Gene Delivery System Technology Drug Market Size (2020-2031)

6.2 North America Gene Delivery System Technology Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Gene Delivery System Technology Drug Market Size by Country (2020-2025)

6.4 North America Gene Delivery System Technology Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Delivery System Technology Drug Market Size (2020-2031)

7.2 Europe Gene Delivery System Technology Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Gene Delivery System Technology Drug Market Size by Country (2020-2025)

7.4 Europe Gene Delivery System Technology Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Delivery System Technology Drug Market Size (2020-2031)

8.2 Asia-Pacific Gene Delivery System Technology Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Delivery System Technology Drug Market Size (2020-2031)

9.2 Latin America Gene Delivery System Technology Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Gene Delivery System Technology Drug Market Size by Country (2020-2025)

9.4 Latin America Gene Delivery System Technology Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Delivery System Technology Drug Market Size (2020-2031)

10.2 Middle East & Africa Gene Delivery System Technology Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Biogen

11.1.1 Biogen Company Details

11.1.2 Biogen Business Overview

11.1.3 Biogen Gene Delivery System Technology Drug Introduction

11.1.4 Biogen Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.1.5 Biogen Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Gene Delivery System Technology Drug Introduction

11.2.4 Novartis Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Details

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Gene Delivery System Technology Drug Introduction

11.3.4 Gilead Sciences Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.3.5 Gilead Sciences Recent Development

11.4 Sarepta Therapeutics

11.4.1 Sarepta Therapeutics Company Details

11.4.2 Sarepta Therapeutics Business Overview

11.4.3 Sarepta Therapeutics Gene Delivery System Technology Drug Introduction

11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.4.5 Sarepta Therapeutics Recent Development

11.5 Alnylam Pharmaceuticals

11.5.1 Alnylam Pharmaceuticals Company Details

11.5.2 Alnylam Pharmaceuticals Business Overview

11.5.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Introduction

11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.5.5 Alnylam Pharmaceuticals Recent Development

11.6 Amgen

11.6.1 Amgen Company Details

11.6.2 Amgen Business Overview

11.6.3 Amgen Gene Delivery System Technology Drug Introduction

11.6.4 Amgen Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.6.5 Amgen Recent Development

11.7 Spark Therapeutics

11.7.1 Spark Therapeutics Company Details

11.7.2 Spark Therapeutics Business Overview

11.7.3 Spark Therapeutics Gene Delivery System Technology Drug Introduction

11.7.4 Spark Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.7.5 Spark Therapeutics Recent Development

11.8 Akcea Therapeutics

11.8.1 Akcea Therapeutics Company Details

11.8.2 Akcea Therapeutics Business Overview

11.8.3 Akcea Therapeutics Gene Delivery System Technology Drug Introduction

11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.8.5 Akcea Therapeutics Recent Development

11.9 bluebird bio

11.9.1 bluebird bio Company Details

11.9.2 bluebird bio Business Overview

11.9.3 bluebird bio Gene Delivery System Technology Drug Introduction

11.9.4 bluebird bio Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.9.5 bluebird bio Recent Development

11.10 Sunway Biotech

11.10.1 Sunway Biotech Company Details

11.10.2 Sunway Biotech Business Overview

11.10.3 Sunway Biotech Gene Delivery System Technology Drug Introduction

11.10.4 Sunway Biotech Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.10.5 Sunway Biotech Recent Development

11.11 SIBIONO

11.11.1 SIBIONO Company Details

11.11.2 SIBIONO Business Overview

11.11.3 SIBIONO Gene Delivery System Technology Drug Introduction

11.11.4 SIBIONO Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.11.5 SIBIONO Recent Development

11.12 AnGes

11.12.1 AnGes Company Details

11.12.2 AnGes Business Overview

11.12.3 AnGes Gene Delivery System Technology Drug Introduction

11.12.4 AnGes Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.12.5 AnGes Recent Development

11.13 Orchard Therapeutics

11.13.1 Orchard Therapeutics Company Details

11.13.2 Orchard Therapeutics Business Overview

11.13.3 Orchard Therapeutics Gene Delivery System Technology Drug Introduction

11.13.4 Orchard Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.13.5 Orchard Therapeutics Recent Development

11.14 Human Stem Cells Institute

11.14.1 Human Stem Cells Institute Company Details

11.14.2 Human Stem Cells Institute Business Overview

11.14.3 Human Stem Cells Institute Gene Delivery System Technology Drug Introduction

11.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Technology Drug Business (2020-2025)

11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Biogen

Novartis

Gilead Sciences

Sarepta Therapeutics

Alnylam Pharmaceuticals

Amgen Inc

Spark Therapeutics

Akcea Therapeutics

Bluebird bio

Sunway Biotech

Sibiono

AnGes

Orchard Therapeutics

Human Stem Cells Institute

List of Tables

Table 1. Global Gene Delivery System Technology Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Viral Gene Delivery System

Table 3. Key Players of Non-viral Gene Delivery System

Table 4. Global Gene Delivery System Technology Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Gene Delivery System Technology Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Gene Delivery System Technology Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Gene Delivery System Technology Drug Market Share by Region (2020-2025)

Table 8. Global Gene Delivery System Technology Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Gene Delivery System Technology Drug Market Share by Region (2026-2031)

Table 10. Gene Delivery System Technology Drug Market Trends

Table 11. Gene Delivery System Technology Drug Market Drivers

Table 12. Gene Delivery System Technology Drug Market Challenges

Table 13. Gene Delivery System Technology Drug Market Restraints

Table 14. Global Gene Delivery System Technology Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Gene Delivery System Technology Drug Market Share by Players (2020-2025)

Table 16. Global Top Gene Delivery System Technology Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System Technology Drug as of 2024)

Table 17. Ranking of Global Top Gene Delivery System Technology Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Gene Delivery System Technology Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Gene Delivery System Technology Drug, Headquarters and Area Served

Table 20. Global Key Players of Gene Delivery System Technology Drug, Product and Application

Table 21. Global Key Players of Gene Delivery System Technology Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Gene Delivery System Technology Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Gene Delivery System Technology Drug Revenue Market Share by Type (2020-2025)

Table 25. Global Gene Delivery System Technology Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Gene Delivery System Technology Drug Revenue Market Share by Type (2026-2031)

Table 27. Global Gene Delivery System Technology Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2020-2025)

Table 29. Global Gene Delivery System Technology Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2026-2031)

Table 31. North America Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Gene Delivery System Technology Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Gene Delivery System Technology Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Gene Delivery System Technology Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Gene Delivery System Technology Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Gene Delivery System Technology Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Gene Delivery System Technology Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Gene Delivery System Technology Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Gene Delivery System Technology Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Biogen Company Details

Table 47. Biogen Business Overview

Table 48. Biogen Gene Delivery System Technology Drug Product

Table 49. Biogen Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 50. Biogen Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Gene Delivery System Technology Drug Product

Table 54. Novartis Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 55. Novartis Recent Development

Table 56. Gilead Sciences Company Details

Table 57. Gilead Sciences Business Overview

Table 58. Gilead Sciences Gene Delivery System Technology Drug Product

Table 59. Gilead Sciences Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 60. Gilead Sciences Recent Development

Table 61. Sarepta Therapeutics Company Details

Table 62. Sarepta Therapeutics Business Overview

Table 63. Sarepta Therapeutics Gene Delivery System Technology Drug Product

Table 64. Sarepta Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 65. Sarepta Therapeutics Recent Development

Table 66. Alnylam Pharmaceuticals Company Details

Table 67. Alnylam Pharmaceuticals Business Overview

Table 68. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product

Table 69. Alnylam Pharmaceuticals Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 70. Alnylam Pharmaceuticals Recent Development

Table 71. Amgen Company Details

Table 72. Amgen Business Overview

Table 73. Amgen Gene Delivery System Technology Drug Product

Table 74. Amgen Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 75. Amgen Recent Development

Table 76. Spark Therapeutics Company Details

Table 77. Spark Therapeutics Business Overview

Table 78. Spark Therapeutics Gene Delivery System Technology Drug Product

Table 79. Spark Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 80. Spark Therapeutics Recent Development

Table 81. Akcea Therapeutics Company Details

Table 82. Akcea Therapeutics Business Overview

Table 83. Akcea Therapeutics Gene Delivery System Technology Drug Product

Table 84. Akcea Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 85. Akcea Therapeutics Recent Development

Table 86. bluebird bio Company Details

Table 87. bluebird bio Business Overview

Table 88. bluebird bio Gene Delivery System Technology Drug Product

Table 89. bluebird bio Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 90. bluebird bio Recent Development

Table 91. Sunway Biotech Company Details

Table 92. Sunway Biotech Business Overview

Table 93. Sunway Biotech Gene Delivery System Technology Drug Product

Table 94. Sunway Biotech Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 95. Sunway Biotech Recent Development

Table 96. SIBIONO Company Details

Table 97. SIBIONO Business Overview

Table 98. SIBIONO Gene Delivery System Technology Drug Product

Table 99. SIBIONO Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 100. SIBIONO Recent Development

Table 101. AnGes Company Details

Table 102. AnGes Business Overview

Table 103. AnGes Gene Delivery System Technology Drug Product

Table 104. AnGes Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 105. AnGes Recent Development

Table 106. Orchard Therapeutics Company Details

Table 107. Orchard Therapeutics Business Overview

Table 108. Orchard Therapeutics Gene Delivery System Technology Drug Product

Table 109. Orchard Therapeutics Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 110. Orchard Therapeutics Recent Development

Table 111. Human Stem Cells Institute Company Details

Table 112. Human Stem Cells Institute Business Overview

Table 113. Human Stem Cells Institute Gene Delivery System Technology Drug Product

Table 114. Human Stem Cells Institute Revenue in Gene Delivery System Technology Drug Business (2020-2025) & (US$ Million)

Table 115. Human Stem Cells Institute Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Gene Delivery System Technology Drug Picture

Figure 2. Global Gene Delivery System Technology Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Gene Delivery System Technology Drug Market Share by Type: 2024 VS 2031

Figure 4. Viral Gene Delivery System Features

Figure 5. Non-viral Gene Delivery System Features

Figure 6. Global Gene Delivery System Technology Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Gene Delivery System Technology Drug Market Share by Application: 2024 VS 2031

Figure 8. Neurological Diseases Case Studies

Figure 9. Cancer Case Studies

Figure 10. Other Case Studies

Figure 11. Gene Delivery System Technology Drug Report Years Considered

Figure 12. Global Gene Delivery System Technology Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Gene Delivery System Technology Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Gene Delivery System Technology Drug Market Share by Region: 2024 VS 2031

Figure 15. Global Gene Delivery System Technology Drug Market Share by Players in 2024

Figure 16. Global Top Gene Delivery System Technology Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Delivery System Technology Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Gene Delivery System Technology Drug Revenue in 2024

Figure 18. North America Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Gene Delivery System Technology Drug Market Share by Country (2020-2031)

Figure 20. United States Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Gene Delivery System Technology Drug Market Share by Country (2020-2031)

Figure 24. Germany Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Gene Delivery System Technology Drug Market Share by Region (2020-2031)

Figure 32. China Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Gene Delivery System Technology Drug Market Share by Country (2020-2031)

Figure 40. Mexico Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Gene Delivery System Technology Drug Market Share by Country (2020-2031)

Figure 44. Turkey Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Gene Delivery System Technology Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Biogen Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 48. Novartis Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 49. Gilead Sciences Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 52. Amgen Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 53. Spark Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 55. bluebird bio Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 56. Sunway Biotech Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 57. SIBIONO Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 58. AnGes Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 59. Orchard Therapeutics Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 60. Human Stem Cells Institute Revenue Growth Rate in Gene Delivery System Technology Drug Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Gene Delivery or Gene Therapy Drug Market Research Report 2025

Drugs Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene based Therapy Medicinal Market Research Report 2024

Drug Based on Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Delivery System Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

Gene Therapy on Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene based Advanced Therapy Medicinal Market Research Report 2025

Gene based Advanced Therapy Medical Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy on Neurological Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gene Therapy in Cardiovascular Disorder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Gene Therapy Market Research Report 2025

Global Gene Therapy Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Viral Gene Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gene Therapies for Cancer Treatment Market Research Report 2024

Global Delivery System for Gene Therapy Market Research Report 2025

Global Gene Therapy On Cardiovascular Disease Market Research Report 2025

Global Gene Therapy For Cancer Market Research Report 2024

Global Cell and Gene Therapy Market Research Report 2024

Global Gene Delivery Technologies Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions